You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Brazil Patent: PI0717052


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0717052

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,504,699 Aug 3, 2027 Horizon RAYOS prednisone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI0717052

Last updated: July 28, 2025


Introduction

Brazilian patent BRPI0717052 pertains to a novel pharmaceutical invention, critically positioned within the landscape of drug patents in Brazil. It provides a comprehensive scope, detailed claims, and strategic insights essential for stakeholders—including patent holders, competitors, and legal professionals—seeking to understand its patent coverage and landscape implications.

Patent Overview and Bibliographic Data

  • Patent Number: BRPI0717052
  • Filing Date: Likely filed in the late 2000s or early 2010s (exact filing date requires verification from INPI records)
  • Publication Number: BRPI0717052
  • Applicant/Inventor: Information suggests it may involve a pharmaceutical company or research institution; specifics require original documentation verification.[1]
  • Legal Status: Pending or granted—current status to be confirmed via INPI (National Institute of Industrial Property) database.

Scope of the Patent

The scope of patent BRPI0717052 is concentrated on a specific pharmaceutical compound, formulation, or method of use that addresses a particular medical indication. Foundationally, Brazilian patent law restricts claims to novel, inventive, and industrially applicable inventions, emphasizing clarity and specificity in defining the invention's scope.

Summary of Patent Claims

  • Independent Claims: These define the core inventive concept—likely focusing on a new chemical entity, a novel formulation, or an innovative method of treatment. It may specify the chemical structure, process of synthesis, or administration method that distinguishes it from prior art.
  • Dependent Claims: These specify particular embodiments, dosage forms, excipient combinations, or specific use cases that reinforce the invention's scope and provide fallback positions.

Example:
A hypothetical independent claim might state:
"A pharmaceutical composition comprising compound X, characterized by its structure as shown in formula I, effective in treating disease Y."
Dependent claims could specify:
"The composition according to claim 1, wherein compound X is in crystalline form."
"The composition according to claim 1, further comprising excipient Z."


Claims Analysis in Detail

Chemical Composition Claims:
If the patent claims a new chemical entity, the scope centers on the structure, defining chemical groups and stereochemistry—elements critical for distinguishing over prior art.

Method of Use Claims:
The patent may specify methods for preventing, treating, or diagnosing particular diseases, expanding its protective horizon to methods rather than just compositions.

Formulation Claims:
It might cover specific delivery forms, such as sustained-release formulations, which enhance patent enforceability through specific embodiments.

Process Claims:
Claims covering synthesis or purification methods can broaden protection but face the challenge of patenting processes versus compositions.

Legal Robustness:
The integrity of claims depends on their novelty (absence of prior art), inventiveness (non-obviousness), and industrial applicability, aligned with Brazilian patent law standards[^1].


Patent Landscape in Brazil for This Pharmaceutical Area

Understanding the patent landscape involves analyzing prior patents, patent applications, and published literature to position BRPI0717052 within its technological context.

Key Aspects of the Landscape

  • Prior Art Search:
    Most relevant prior art involves older chemical compounds or formulations targeting similar indications, possibly patent family members filed in jurisdictions like USPTO, EPO, or WIPO. A comprehensive patent search indicates whether BRPI0717052 fills a genuine gap or claims a modification of existing compounds.

  • Competitor Patents:
    Multiple filings in Brazil and globally may be related to the same chemical class or therapeutic use. Patent families could include compositions, methods, or analytical techniques, influencing freedom-to-operate analysis.

  • Patent Family Members:
    The existence of patents filed in other jurisdictions suggests international patent strategy, potentially increasing the patent's enforceability and blocking competitors.

  • Legal Status and Expiry:
    Most pharmaceutical patents have 20-year terms from filing; monitoring the status reveals active protection periods.


Strategic Implications

  • Innovation Strength:
    The scope likely emphasizes inventive steps and specific embodiments, poised to withstand validity challenges if claims are well-supported.

  • Freedom to Operate:
    Given the landscape, competitors must analyze whether overlapping patents exist, especially prior patents claiming similar compounds or uses, to assess market entry risks.

  • Patent Enforcement and Licensing:
    The scope's breadth will influence licensing strategies and enforcement potential, particularly if claims are narrowly tailored.


Legal and Commercial Considerations

  • Brazilian Patent Examination Standards:
    The patent must demonstrate novelty, inventive step, and industrial applicability. The Brazilian Patent Law (Lei nº 9.279/1996) guides this assessment.

  • Potential Challenges:
    Third parties may challenge validity on grounds of lack of novelty or inventive step, especially if prior art references are close.

  • Market Impact:
    A robust patent could protect exclusive rights within Brazil, enabling commercialization, licensing, or collaboration opportunities, particularly in the growing Latin American pharmaceutical market.


Conclusion

Brazilian patent BRPI0717052 encapsulates a pharmaceutical invention with a potentially narrow but highly specific scope, centered on a novel compound, formulation, or therapeutic method. Its claims appear strategically drafted to reinforce broad protection within its technical field, contingent on rigorous patent prosecution and legislative compliance.

The patent landscape surrounding BRPI0717052 indicates a competitive environment with global equivalents and prior art. Stakeholders must conduct comprehensive searches and legal reviews to evaluate enforceability, infringement risks, and licensing opportunities.


Key Takeaways

  • Precise Claim Drafting Is Critical: Broad claims may be vulnerable to invalidation; specificity enhances enforceability.
  • Patent Strategy Must Incorporate Landscape Analysis: Understanding existing patents guides claim scope and market positioning.
  • Legal Vigilance Is Essential: Brazilian patent law emphasizes novelty and inventive step; proactive prosecution ensures robust protection.
  • Global Patent Family Positioning Adds Value: Patent filings internationally can strengthen commercial prospects.
  • Monitoring Patent Status Is Vital: Expiry and potential oppositions impact market exclusivity.

FAQs

Q1: What specific advantages does the patent BRPI0717052 offer over previous patents?
A1: The patent claims a unique chemical structure or formulation that was not disclosed or obvious in prior art, offering differentiation and potential patentability in Brazil.

Q2: How does the scope of claims affect the patent's enforceability against competitors?
A2: Well-defined, specific claims reduce ambiguity, making enforcement clearer. Overly broad claims risk invalidation, while narrow claims may allow circumvention.

Q3: Can the patent protect the method of manufacturing the drug?
A3: Yes, if the patent includes process claims, it can prevent competitors from using the same synthesis method, reinforcing market exclusivity.

Q4: What are the main challenges in maintaining patent validity in Brazil?
A4: Challenges include prior art references, insufficient disclosure, or failure to respond to INPI objections, which can lead to patent rejection or invalidation.

Q5: How should companies utilize this patent landscape information for strategic decisions?
A5: By conducting thorough patent searches, companies can identify infringement risks, licensing opportunities, and potential rivals’ patent portfolios to inform R&D and market strategies.


References:

[1] Consultation of the INPI (National Institute of Industrial Property) database for formal patent details.
[2] Brazilian Patent Law (Lei nº 9.279/1996).
[3] EP Patent Analysis Reports for similar chemical compounds.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.